| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0001 | 1 |